Biochemistry, Genetics and Molecular Biology
GTPase
100%
Methylation
100%
Lysine
100%
Dynamics
64%
Phosphotransferase
56%
Kinase
56%
2,5-Dimethoxy-4-iodoamphetamine
50%
IMP Dehydrogenase
50%
Messenger RNA
50%
DEP Domain
50%
Enhancer Region
50%
Transcription Factor Nrf2
30%
PIM1
20%
SOX2
20%
Ubiquitination
17%
PRC2
16%
Acetylation
14%
Pentose Phosphate Pathway
10%
Small Molecule
10%
Cell Death
10%
Cytotoxicity
10%
Antioxidant Responsive Element
10%
Moloney Murine Leukemia Virus
10%
Induced Stem Cells
10%
Guanylate Kinase
8%
Posttranslational Modification
7%
Amino Acid Substitution
7%
Growth Regulation
7%
Mass Spectrometry
7%
Conformation
7%
Protein Interaction
7%
Cell Growth
7%
Protein Structure
7%
Signal Transduction
7%
Enhancer Protein
6%
Integrin
6%
Protein Kinases
6%
Serine
6%
Cancer Cell
6%
mRNA Stability
6%
Tissue Culture
6%
Keyphrases
Lysine Methylation
50%
PLoS
50%
2-oxoquinoline
50%
GTPase Domain
50%
Nucleolar Activity
50%
Go Language
50%
Decapping
50%
P-bodies
50%
Phosphorylation
50%
GATOR1
50%
DEP Domain
50%
Stem Cell Genes
50%
Long Noncoding RNA H19
50%
Ras GTPase
33%
Guanylate Kinase
16%
Metabolic Compartments
16%
Purine Biosynthesis
16%
Temple
16%
ETP-ALL
16%
Lysine Ubiquitination
10%
RASopathies
10%
PhosphoSitePlus
10%
Pentose Phosphate Shunt
10%
Nucleostemin
8%
Guanine nucleotide Biosynthesis
8%
Gliomagenesis
8%
Nucleolar Hypertrophy
8%
Nucleolar Stress
8%
Nucleolar Functions
8%
Pharmacological Inactivation
8%
Induced Stem Cell
8%
Neuroendocrine Prostate Cancer
8%
Xenograft Model
7%
MRNA Stability
7%
Body Activity
7%
Multiple Cancers
7%
Tumor Subtype
7%
Tissue Culture
7%
Protein Kinase
7%
Phenotypic Change
7%
PIM-1
7%
Protein Abundance
7%
Kinase Inhibitor
7%
Cancer Treatment
7%
GATOR2
7%
Integrin 1
7%
Rag GTPases
7%
Body Protein
7%
Prostate Cancer Cells
7%
Lineage Plasticity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Protein Kinases
50%
Mouse
50%
Phosphotransferase
50%
Protein Kinase Inhibitor
50%
Multiple Cancer
50%
Cancer Growth
50%
Malignant Neoplasm
50%
Tumor Growth
50%
Leukemia
50%
RNA H19
50%
Pharmacokinetics
50%
Transcription Factor Nrf2
37%
Neoplasm
25%
Antioxidant
12%
Pentose Phosphate
12%
Phosphotransferase Inhibitor
12%
Initiation Factor 4B
12%
Cancer Resistance
12%
Cytotoxicity
12%